pH-Sensitive Peptide Nanoparticles for Tumor Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pH-sensitive drug and gene delivery vehicles are ineffective for tumor targeting due to requiring large pH changes, being large and costly, and failing to protect cargo from enzymatic degradation, with existing technologies often relying on inefficient endocytosis and being susceptible to immune responses.
Innovation Solution
Development of short, pH-sensitive peptides that form nanoparticles capable of solubility changes in response to weakly acidic environments, protecting cargo and releasing it at tumor sites without the need for endocytosis, using amino acid sequences with histidines and nonpolar amino acids for enhanced solubility and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pH-sensitive delivery vehicles are designed to respond to large pH changes (pH 7.4 to pH 4-6), then they can trigger phase transition and release cargo, but they require pH conditions (pH 4-6) that are not present in typical extracellular tumor environments, making them ineffective for tumor targeting
Solution Approach 1:
The patent modifies the pH sensitivity parameter of the delivery vehicle by incorporating specific amino acid sequences (particularly histidine residues) that enable response to smaller pH changes (0.5-1.0 unit) occurring in extracellular tumor environments, rather than requiring the large pH changes (2-3 units) needed by conventional systems. This parameter change allows the vehicle to function reliably in the actual tumor microenvironment.
2Stability of the object's composition
If nanoparticles are made large (typically ~200 nm) to maintain structural integrity, then they remain intact during circulation, but they are easily lost to the reticuloendothelial system during blood circulation
Solution Approach 1:
The patent divides the delivery system into two functional components: a small peptide vehicle (5-20 amino acids) that evades immune detection and circulates efficiently, and a cargo payload that is delivered to the target. This segmentation allows the vehicle to remain small enough to avoid reticuloendothelial clearance while maintaining sufficient stability through the pH-triggered conformational change mechanism.
3Ease of manufacture
If peptides are made short to reduce cost and improve synthesis efficiency, then manufacturing cost decreases, but they may lack sufficient stability and protective capability for cargo
Solution Approach 1:
The patent creates a composite peptide structure combining hydrophobic amino acids (for cargo binding and membrane interaction) with histidine residues (for pH sensing and conformational change). This composite design at the molecular level enables short peptides (5-20 amino acids) to achieve both manufacturing efficiency and sufficient cargo protection capability through the synergistic functions of different amino acid components.
4Reliability
If conventional pH-sensitive peptides (GALA, pHLIP) are used to protect cargo from enzymatic degradation, then cargo protection is provided, but they are relatively large (30 amino acids for GALA) which increases synthesis cost
Solution Approach 1:
The patent extracts only the essential functional elements needed for cargo protection and pH-responsive delivery, eliminating non-essential sequences. By taking out just the critical histidine-containing motifs required for pH sensing and conformational change, the patent creates minimal-length peptides (5-20 amino acids) that retain cargo protection capability while dramatically reducing synthesis cost compared to full-length GALA (30 aa) or pHLIP peptides.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptides enable efficient, non-toxic, and cost-effective delivery of drugs and genes to tumors by dissolving at acidic pH, avoiding enzymatic degradation and enhancing bioavailability, with improved potency and reduced toxicity.
Implementation Method 1
a pH change may induce a configurational change of the delivery vehicle, which will be termed a pH-induced phase transition
Implementation Method 2
short, pH-sensitive peptides that form nanoparticles capable of solubility changes in response to weakly acidic environments
Data Source
AI summary
A new nanoscale carrier made by one or more pH-sensitive peptides is provided for delivery of a biologically active substance. The peptides are composed of pH-sensitive hydrophilic and hydrophobic amino acids in the backbone. As the pH environment changes from physiological pH level to a weakly acidic environment such as near a tumor site (pH.about.6.5-6.9), the peptides may dissolve, releasing the biological substance. Also provided are the delivery methods and related kits.